Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 189, Supplement 653
The 86th Annual Meeting of The German Physiological Society
3/25/2007-3/28/2007
Hannover, Germany


LEUKOCYTE DIFFERENTIATION FROM MOUSE EMBRYONIC STEM CELLS AS A NOVEL IN VITRO MODEL FOR CELLULAR DEFENCE
Abstract number: P26-L7-10

Hannig1 M, Ruhe1 C, Noack1 Y, Sauer1 H, Wartenberg1 M

1Institute of Polymer Research, GKSS Research, Center, Teltow; Department of Physiology, Justus-Liebig-University Giessen

Embryoid bodies (EB) derived from mouse embryonic stem cells were used to establish a new in vitro model for cellular defence processes. Therefore, the differentiation of endothelial cells (analyzed by PECAM-1 and VE-cadherin) and leukocytes (detected by CD45) in the EB, especially neutrophils (CD16- positive or expression of neutrophil antigen) and macrophages (identified by the expression of CD68 and CD14) were analyzed in a time-dependent manner. To simulate inflammation, EBs were treated with lipopolysaccharide (LPS) originating from E. coli K-235. A concentration-dependent increase in CD14-expression was observed. Isolated leukocytes responded to 10 mM LPS with Ca2+ signals. Furthermore we used confrontation cultures of EBs with multicellular tumour spheroids (MTS), which were generated from the 4T1 mouse mammary carcinoma cell line. During tumour-induced angiogenesis we observed an invasion of leukocytes into the MTS. Following 4 days of co-culture CD45+ leukocytes originating from the EB were identified all over the confrontation culture, whereas CD68+ macrophages were mainly located at the periphery of the MTS. Our findings indicate that embryonic stem cell-derived EBs provide a suitable in vitro model for cellular defence.

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 189, Supplement 653 :P26-L7-10

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE